Acadia Pharmaceutica (ACAD)
$40.74
0.94 (2.26%)
ACAD Stock Quote Delayed 15 Minutes
Previous Close
$40.74
Market Cap
5.09B
PE Ratio
-19.59
EPS
-2.08
Volume (Avg. Vol.)
4.22M
Day's Range
40.60 - 42.07
52-Week Range
14.01 - 44.85
Dividend & Yield
N/A (N/A)
ACAD Stock Predictions, Articles, and Acadia Pharmaceutica News
5 Top Stock Trades for Wednesday: BA, ACB, PINS
Boeing, Aurora Cannabis, Pinterest, Corning and Acadia Pharmaceuticals were our top stock trades on Wednesday. See the charts now.
Why ACADIA Pharmaceuticals Stock Is Falling Today
ACADIA Pharmaceuticals (ACAD) stock was down more than 6% on Monday as an investigation was launched to examine the efficacy of one of its drugs.
Why ACADIA Pharmaceuticals Inc. Stock Is Plunging Today
ACADIA Pharmaceuticals(ACAD) stock was falling hard today on a report with concerns about its Parkinson's drug Nuplazid.
Is Now the Time to Buy Into These 5 Biotech ETFs?
After a painful 2016, biotech stocks are recovering this year. What lies ahead? Let's look at 5 biotech ETFs to find out
Acadia Pharmaceuticals Inc. (ACAD) Flirts With a Pfizer Inc. (PFE) Buyout
Acadia stock took a big leap on rumors that Pfizer (PFE) is interested in a buyout. But ACAD stock investors shouldn't get too excited yet.
Hottest Manufacturing Stocks Now – MBRX ZYNE SID ONVO
The following stocks were the biggest movers and shakers in the Manufacturing sector today.
Biggest Movers in Manufacturing Stocks Now – AKBA ABIO GLMD KMPH
The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.
Hottest Manufacturing Stocks Now – OSIR ACAD AKAO VHI
The following stocks were moving the Manufacturing sector today.
19 Biotechnology Stocks to Sell Now
This week, the ratings of 19 Biotechnology stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
32 Biotechnology Stocks to Sell Now
The ratings of 32 Biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
41 Biotechnology Stocks to Sell Now
The overall ratings of 41 Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
Navellier Ratings
Powered by Portfolio GraderTotal Grade
A
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!
